WeightWatchers has stopped selling compounded weight-loss drugs, and its partnership with Novo may prove more attractive to employer-sponsored health plans in the long run, Boyd said.

WW International (WW) shares higher with Q2 results post-bankruptcy, boosted by Clinical unit growth. Discover revenue ...